BDBM395269 N-{4-[rel-(4aR,5aS)-3-Anilino-5a-methyl-4,6-dioxo-1,4,4a,5,5a,6-hexahydrocyclopropa[f]indol-2-yl]pyridin-2-yl}-1-methylcyclopropanecarboxamide::US10308629, Example 33

SMILES CC1(C(=O)Nc2cc(-c3[nH]c4c(c3Nc3ccccc3)C(=O)[C@@H]3C[C@]3(C)C4=O)ccn2)CC1

InChI Key InChIKey=MNAHTRHIRQZUNW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 395269   

TargetMitotic checkpoint serine/threonine-protein kinase BUB1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 395269BDBM395269(US10308629, Example 33 | N-{4-[rel-(4aR,5aS)-3-Ani...)
Affinity DataIC50: 110nMAssay Description:Bub1-inhibitory activities of compounds described in the present invention were quantified using a time-resolved fluorescence energy transfer (TR-FRE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent